Investigating the same primary endpoint, TRANSCEND-T2D-2 (NCT06260722) will compare retatrutide to semaglutide in people with inadequately controlled T2D (treated with oral glucose-lowering treatments) over 26 months
Strength consistency, capsule presentation, raw material accountability, documentation, labeling accuracy, and finished-product handling all matter
KPV is based on a sequence that is found in a human peptide hormone
It Ensures Consistency: You can be confident that aliquot #10 is just as potent as aliquot #1
That said, they are most effective as part of a supervised plan, and our physician-supervised team, the same clinicians who lead our Fleming Island medical weight-loss programs, will talk through what makes sense for your goals before you start